Skip navigation
>»
RSS feed for this page
Know something we don't? Submit a conference announcement
Choose Category:

Virology meetings & conferences

17 meetings & conferences listed in Virology 

International Conference in Modeling Health Advances (ICMHA'12)
United States
California
10/24/2012

International Conference in Modeling Health Advances (ICMHA'12)

San Francisco, USA, 24-26 October, 2012

The International Conference in Modeling Health Advances 2012 will take place in San Francisco, USA, 24-26 October, 2012.

A host of new diseases, like HIV/AIDS, BSE, Avian Flu, West Nile Virus and others have appeared on the scene during the last twenty five years and undoubtedly, more will come in the coming years. To tackle these illnesses, the cooperation of modelers, mathematicians, statisticians, computer scientists, and others, and of researchers from the medical community is absolutely essential. Modeling is important because it gives important insight into the method of treatment. In the case of HIV/AIDS, for example, mathematical modeling indicated that a combination of both protease inhibitors and reverse transcriptase inhibitors would be far more effective than any one of these two drugs.

The purpose of this conference is to bring all the people working in the area of epidemiology under one roof and encourage mutual interaction.

The conference ICMHA'12 is held under the World Congress on Engineering and Computer Science WCECS 2012. The WCECS 2012 is organized by the International Association of Engineers (IAENG), a non-profit international association for engineers and computer scientists. The congress has the focus on the frontier topics in the theoretical and applied engineering and computer science subjects. The last IAENG conference has attracted more than five hundred participants from over 30 countries. All submitted papers will be under peer review and accepted papers will be published in the conference proceeding (ISBN: 978-988-19251-6-9). The abstracts will be indexed and available at major academic databases. The accepted papers will also be considered for publication in the special issues of the journal Engineering Letters, in IAENG journals and in edited books by publishers like Springer.

Computer Scientist, Physician Researcher, Virologist
Society for Immunotherapy of Cancer 27th Annual Meeting
United States
Maryland
10/26/2012

Society for Immunotherapy of Cancer 27th Annual Meeting

October 26-28, 2012 North Bethesda, Maryland

The SITC 27th Annual Meeting allows for scientific exchange of the most cutting-edge preclinical and clinical data on immunotherapies and biological therapy of cancer. The program included dynamic presentations, interactive panel discussions and scientific posters on the most timely topics in cancer immunotherapy as well as vital information on clinical trial design and regulatory issues to advance collaboration and translation of cancer immunotherapies.

SITC is ideally positioned to meet the identified needs of our attendees. SITC’s strength lies in its history of organizing successful scientific conferences that gather clinicians and scientists from around the globe to interact and discuss the most important issues in cancer immunotherapy. By addressing these needs, SITC advances effective, efficient research and interaction on promising cancer therapies with biological and immunological agents. Through its integrated programs, SITC promotes productive collaboration among scientists and with other organizations in the field. Ultimately this scientific exchange and collaborative environment will lead to better cancer patient outcomes with novel cancer immunotherapies.

The SITC 27th Annual Meeting program format and content is designed to address identified needs/practice gaps and promotes:

Exchange between basic and clinical researchers, thus improving the caliber of the science and promoting translation
Discussion on potential hurdles in cancer immunotherapy from the trial design and regulatory perspective
Integrated understanding of the state of cancer immunotherapy research in today’s environment, identification of potential funding opportunities, and mentoring of junior investigators
Discussion of novel therapies and applications based on the research presented
Interactions with industry to promote access to novel agents for clinical development

Intended Audience

The audience for this program is basic and clinical investigators from academic institutions, industry and regulatory agencies, including clinicians, basic and translational researchers, graduate students, postdoctoral fellows, and allied health professionals involved in cancer research.

Program Goals

Exchange information on the most recent advances in tumor immunology and cancer immunotherapy
Convey recent advances in biology and immunotherapy as they relate to specific cancers and various immunotherapy modalities, cell subsets, animal models, and aspects of negative regulation in the tumor microenvironment
Identify promising research opportunities, new techniques and clinical applications incorporating these advances
Establish dialogue between academia, industry and government on these advances

Expected Learner Outcomes

Upon completion of this program, the participants will be able to:

Summarize the most recent advances in tumor immunology and cancer immunotherapy
Integrate recent advances in cancer immunology and immunotherapy into basic, clinical and translational research
Incorporate new research and techniques into clinical applications for cancer immunotherapy
Establish and solidify collaborations among the various members of academia, industry, government and clinical practices to promote clinical evaluation of these advances in more efficient trials

Allied Health Professional, Graduate Student, Oncologist, Physician Researcher, Postdoctoral Fellow, Virologist
Annual Biomedical Research Conference for Minority Students
United States
California
11/07/2012

Annual Biomedical Research Conference for Minority Students

November 7-10, 2012 San Jose, California

ABRCMS
American Society for Microbiology Education Department
1752 N Street, NW
Washington, DC 20036

Ph: 202-942-9348
Fax: 202-403-3513

Email:abrcms@asmusa.org

African American, Latino/Hispanic, Novice Researcher, Pacific Islander, Student Researcher, Undergraduate
10th International Rotavirus Symposium
Thailand
09/19/2012

10th International Rotavirus Symposium

19 - 21 September 2012 Bangkok, Thailand

The 10th International Rotavirus Symposium will be held 19-21 September, 2012 in Bangkok, Thailand. It will bring together interested stakeholders to provide an update on new data and relevant research that will inform public health agendas related to prevention of rotavirus gastroenteritis.

Main Session Topics
Participants will discuss the latest results of trials of new rotavirus vaccines in developing country settings, issues in vaccine policy and introduction, and early post-marketing data on vaccine impact and safety. Scheduled sessions include:

* Update on rotavirus vaccines
* Early experiences with introduction of new rotavirus vaccines
* Epidemiology and burden of rotavirus disease
* The pipeline for rotavirus vaccines
* The next steps for rotavirus vaccines

Physician Researcher, Public Health Expert, Virologist
Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2012)
United States
California
09/09/2012

Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2012)

September 9-12 San Francisco, California

Intended Audience

ICAAC 2012 is designed to meet the needs of health care professionals, particularly physicians, clinical microbiologists, researchers, and pharmacists, specializing in infectious diseases. Current trends will be covered regarding:

Antimicrobial Resistance

Mycology

Clinical Trials

Nosocomial Infections

Community-Acquired Infections

Parasitology

Epidemiology

Pharmacology

Susceptibility Studies

HIV/AIDS and other Retroviruses

Vaccines and Immunology

Laboratory Diagnostics

Virology

Microbial Pathogenesis

Questions or Comments?

American Society for Microbiology- Meetings Department
1752 N Street NW
Washington, DC 20036

icaac@asmusa.org
(202) 737-3600

Immunologist, Microbiologist, Physician Researcher, Public Health Expert, Virologist
Multidisciplinary Integrated Approaches to Understand Evasion of Host Immune Responses by Pathogens
United Kingdom
06/20/2012

Multidisciplinary Integrated Approaches to Understand Evasion of Host Immune Responses by Pathogens

Wednesday, 20 June 2012 London United Kingdom

Infectious disease are still a major cause of morbidity and mortality worldwide. Successful treatment and prevention are still hampered by insufficient understanding of the subtle interactions that govern the infectious processes. Evasion of the natural or vaccine-induced immune response is often at the basis of the onset and escalation of disease and can also result in the persistence of the pathogen in chronic infections. This EuroSciCon meeting will be a premier forum for the presentation of cutting-edge research on key mechanisms used by different classes of pathogens to evade host innate and acquired immunity. The meeting will contribute to steer the course of future research into more rational measures to prevent disease in humans and animals.

Meeting Chair: Dr Pietro Mastroeni, Cambridge University, UK

Physician Researcher, Virologist
Li Ka Shing Institute of Virology and Gairdner Foundation Symposium: Meeting the Challenge of Emerging, Acute and Persistent Viral Diseases
Canada
05/31/2012

Li Ka Shing Institute of Virology and Gairdner Foundation Symposium: Meeting the Challenge of Emerging, Acute and Persistent Viral Diseases

May 31 & June 1, 2012 Allard Theatre, Katz Centre for Health Research, University of Alberta, Edmonton, Canada

The symposium will focus on the viral pathogenesis, immune responses and potential of novel antivirals, and vaccines both prophylactic and therapeutic on these viruses.

Address & Contact Information

Li Ka Shing Institute of Virology
6010 Katz Centre for Health Research
Edmonton, AB T6G 2E1
CANADA

Phone: +1 (780) 492-1084
Fax: +1 (780) 492-5304

Email: karin.fodor@ualberta.ca

Pharmaceutical Scientist, Pharmacologist, Physician Researcher, Public Health Expert, Virologist
23rd Conference of the Asia Pacific Association for the Study of the Liver
Singapore
03/07/2013

23rd Conference of the Asia Pacific Association for the Study of the Liver

March 7-10, 2013 Singapore

2013 is the year that APASL returns to the place where it all began 35 years ago: Singapore. Since being formed in 1978, the APASL Conference has grown dramatically to become the largest hepatology congress in the Asia Pacific. Accessing APASL will enable you to improve your practice. Learn about the latest developments, state-of-the-art pioneering research updates and new technological advancements in the field. The Conference is also a unique opportunity for you to learn from the experts and network with colleagues from across the region.

Who should attend APASL 2013?
Clinicians, physicians, scientists, researchers, academics, nurses, residents and allied health professionals in hepatology and related fields including gastroenterology, pathology, radiology, surgery, virology, oncology, and others.

Please do not hesitate to contact the Conference Secretariat if you require any additional information or assistance. Please address all correspondence to:

23rd Conference of the Asian Pacific Association for the Study of the Liver

c/o Kenes Asia
PICO Creative Centre
20 Kallang Avenue, 339411
Tel: +65 6292 4710 Fax: +65 6292 4721
E-mail: apaslconference@kenes.com

Allied Health Professional, Gastroenterologist, Hepatologist, Medical Resident, Nurse, Oncologist, Pathologist, Physician, Physician Researcher
6th Forum on Respiratory Tract Infections
Spain
11/28/2012

6th Forum on Respiratory Tract Infections

November 28-30 2012 Barcelona, Spain

The 6th RTI Forum in the series is now proposed in response to important advances and novel issues in the matters of epidemiological, diagnostic and therapeutic events, including significant new agents, both anti-microbial and adjunctive, early recognition of bacterial disease (and rapid pathogen identification) and preventative vaccines. Most of these will be approaching the clinical interface within the next 2-3 years. They urgently merit both objective interdisciplinary evaluation and wider dissemination to leaders in their clinical application. The 6th RTI Forum offers a unique opportunity to discuss these issue with experts in respiratory Infection in an intimate and informal atmosphere and we hope to welcome you in Barcelona!

Topics for RTI 2012 Forum include:

The continued role of Ps aeruginosa in broncho-pulmonary disease.
The “Last” antibiotic decade (the possible future without antibiotics)
The re-emergence of preventable respiratory disease: pertussis, measles, varicella, mumps
Unanswered questions in AECB – what data must new trials provide
Inhaled therapy – an expanding future?
Nosocomial MRSA pneumonia
CA-MRSA
Ventilator-associated-pneumonia (or VA tracheitis)
Tuberculosis / MDR-TB: non-MTB mycobacteria in RTI
Current role of pneumococcal vaccines: efficacies and deficiencies?
Community acquired pneumonia
Healthcare Associated pneumonia
Development of the vancomycins
Aspergillosis
Influenza then and now
Influenza vaccines (after Bird flu where next)
Faculty Advisory Board: Any Questions?

Secretariat - Publicreations
74, Bd d’Italie, Monte Carlo - MC98000 (Monaco)
Ph.: +377 9797 3555 - Fax: +377 9797 3550
Email: rti@publicreations.com

Chest Physician, Epidemiologist, Pharmacologist, Physician, Physician Researcher, Public Health Expert, Pulmonolgist, Virologist
Viral Hepatitis Congress 2012
Germany
09/07/2012

Viral Hepatitis Congress 2012

7 – 9 September 2012 The Johann Wolfgang Goethe University Frankfurt Germany

With many new breakthroughs and an increasing array of treatment options, this is an exciting time for healthcare professionals involved in the management of viral hepatitis.

However, as we are entering a particularly remarkable era of innovation, keeping up with, and interpreting, this new information can seem like a daunting prospect. The aim of our educational congress is to provide a concise update over two days on all the new advances in viral hepatitis in an interesting, meaningful way. There will be a particular focus on providing practical guidance on what the new scientific developments mean for the present and future management of our daily clinical practice.

Interaction between the audience and experts will be encouraged throughout the meeting through Q&A sessions, roundtable discussions and point-counterpoint debates.

Contact Us:

For all enquiries relating to this event:

The Viral Hepatitis Congress
Organising Secretariat
KnowledgePoint360 Group
Victoria Mill
Windmill Street
Macclesfield SK11 7HQ, UK

Tel: +44 (0) 1625 664392 Fax: +44 (0) 1625 664391
Email: hep@kp360group.com

Hepatologist, Physician, Physician Researcher, Virologist

2next